Juliette Raedemaeker

Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen‐specific T cell responses

A. Kelleher, S. Turville, A. Ospina Stella, 2022, American journal of hematology.

COVID-19, impact on myeloma patients

M. Vekemans, A. Kentos, M. Delforge, 2020, Annals of Hematology.

Kaposi sarcoma after kidney transplantation

A. Camboni, N. Kanaan, L. Marot, 2019, BMJ Case Reports.